Few semiconductors exist to electronically interface
with biological material, and graphene is one of them.

Archer’s biochip development involves integrating graphene with miniaturised lab-on-a-chip platforms for advanced medical diagnostics.

A key factor in biochip development is the convergence of nanodevice fabrication and biochemistry. Biochips take advantage of device miniaturisation to enable efficient diagnostics. They combine several laboratory functions in regions on the same chip to process, detect and analyse biological specimens. To pave the way for on-chip multiplex diagnostics, Archer is developing a graphene-based biochip.

Archer’s Biochip

Biochips are some of the most sophisticated technologies in medical diagnostics. We're designing and building our biochip in world-class clean-room facilities and engineering materials at the atom-scale.

Archer’s biochip innovation aims to integrate graphene field effect transistors (known as "gFETs") into advanced fluidic systems. In the future, this could potentially lead to greater efficiency in analyte detection as part of a medical diagnostic workflow.

We're developing our biochip for digitising biologically relevant signals like those from viruses or bacteria. Our progress is focused on continuously scaling and advancing our biochip technology end-to-end across hardware and software.

Partner with us to develop, scale, and deploy biochip technology.